Johnson & Johnson stock pre-market at EUR 227.08: plus 0.29 percent
Published on 10/07/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson stock was at EUR 227.08 in pre-market trading at 8:23 a.m. CEST on October 7, 2026, up 0.29 percent versus the Lang & Schwarz prior close of EUR 226.43 on October 6, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 226.85 and an ask of EUR 227.30. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.
Previous session
The Lang & Schwarz reference close was EUR 226.43 on October 6, 2026.
Johnson & Johnson reports two-year ICOTYDE data
In a Johnson & Johnson press release dated October 2, 2026, the company announced two-year results from the Phase 3 ICONIC-TOTAL study of ICOTYDE in adults and adolescents with plaque psoriasis affecting high-impact sites. At Week 112, 70 percent of ICOTYDE-treated patients had clear or almost clear skin, while site-specific complete skin clearance was reported for 60 percent of patients with scalp psoriasis, 89 percent with genital psoriasis and 63 percent with psoriasis affecting the hands or feet.
